Table 2 Bivariate analysis between clinical variables and NSCs effect size.
Effect Size for Infarct Volume | Effect Size for mNSS | ||||
|---|---|---|---|---|---|
Correlations with | r | p | Correlations with | r | p |
Time NSCs administered poststroke | −0.472 | 0.017 | Time NSCs administered poststroke | −0.508 | 0.022 |
Use of immunosuppression | — | 0.048 | Use of immunosuppression | — | 0.038 |
Type of NSC source (human <rat <mouse) | 0.465 | 0.019 | Â | Â | Â |